Gurevich Igor, Flores Anthony M, Aneskievich Brian J
Graduate Program in Pharmacology/Toxicology, Department of Pharmaceutical Sciences, School of Pharmacy, University of Connecticut, Storrs, CT 06269, USA.
Toxicol Appl Pharmacol. 2007 Sep 15;223(3):288-98. doi: 10.1016/j.taap.2007.05.019. Epub 2007 Jun 14.
Nuclear receptors (NRs) rely on coregulator proteins to modulate transcription of target genes. NR coregulators can be broadly subdivided into coactivators which potentiate transcription and corepressors which silence gene expression. The prevailing view of coregulator action holds that in the absence of agonist the receptor interacts with a corepressor via the corepressor nuclear receptor (CoRNR, "corner") box motifs within the corepressor. Upon agonist binding, a conformational change in the receptor causes the shedding of corepressor and the binding of a coactivator which interacts with the receptor via NR boxes within the coregulator. This view was challenged with the discovery of RIP140 which acts as a NR corepressor in the presence of agonist and utilizes NR boxes. Since then a number of other corepressors of agonist-bound NRs have been discovered. Among them are LCoR, PRAME, REA, MTA1, NSD1, and COPR1 Although they exhibit a great diversity of structure, mechanism of repression and pathophysiological function, these corepressors frequently have one or more NR boxes and often recruit histone deacetylases to exert their repressive effects. This review highlights these more recently discovered corepressors and addresses their potential functions in transcription regulation, disease pharmacologic responses and xenobiotic metabolism.
核受体(NRs)依靠共调节蛋白来调节靶基因的转录。NR共调节蛋白可大致分为增强转录的共激活因子和使基因表达沉默的共抑制因子。关于共调节蛋白作用的主流观点认为,在没有激动剂的情况下,受体通过共抑制因子内的共抑制因子核受体(CoRNR,“转角”)框基序与共抑制因子相互作用。激动剂结合后,受体内的构象变化导致共抑制因子脱落,以及与共调节蛋白内NR框相互作用的共激活因子的结合。RIP140的发现对这一观点提出了挑战,RIP140在激动剂存在的情况下作为NR共抑制因子起作用,并利用NR框。从那时起,又发现了许多其他与激动剂结合的NR共抑制因子。其中包括LCoR、PRAME、REA、MTA1、NSD1和COPR1。尽管它们在结构、抑制机制和病理生理功能上表现出很大的多样性,但这些共抑制因子通常有一个或多个NR框,并且经常招募组蛋白脱乙酰酶来发挥其抑制作用。这篇综述重点介绍了这些最近发现的共抑制因子,并探讨了它们在转录调控、疾病药理反应和外源性物质代谢中的潜在功能。